Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.01 - $10.42 $295,131 - $766,901
-73,599 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$11.32 - $14.45 $833,140 - $1.06 Million
73,599 New
73,599 $1.06 Million

Others Institutions Holding SQZ

About SQZ Biotechnologies Co


  • Ticker SQZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,248,600
  • Market Cap $1.46M
  • Description
  • SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...
More about SQZ
Track This Portfolio

Track Bbr Partners, LLC Portfolio

Follow Bbr Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bbr Partners, LLC with notifications on news.